Pradaxa Lawsuit Information

Between March 2008 and October 31, 2011, more than 260 fatal bleeding events had been reported worldwide that were caused by or attributed to the anti-clotting drug known as Pradaxa. Patients who had been prescribed Pradaxa and have subsequently suffered adverse events may be entitled to compensation.

Contact our Pradaxa lawyers for more information regarding your eligibility to recover compensation.

Pradaxa is a prescription anti-clotting drug by Behringer Ingelheim that had first been approved for marketing and sales in the European Union on March of 2008. While a large clinical trial of 18,000 patients had shown similar rates of major bleeding events to warfarin (another blood thinning drug), recently, the unusually high reports of adverse effects have caused the Food and Drug Administration to review the bleeding risks associated with Pradaxa.

Many patients are prescribed anticoagulants to prevent stroke or blood clotting in patients undergoing hip replacement surgery, knee replacement surgery, and non-valvular atrial fibrillation.

Bleeding side effects are not unique to Pradaxa, other blood-thinning drugs also report serious and even fatal bleeding as possible side effects. However, Pradaxa related bleeding, is more dangerous than internal bleeding caused by older, traditional blood thinners because there is no antidote for bleeding caused by direct thrombin inhibiters like Pradaxa.

The overwhelming reports of serious and fatal bleeding have caused the FDA to initiate further investigation of the drug Pradaxa. The rate of failure may be indicative of the unsafe formula of the drug, in which case Behringer Ingelheim can be held accountable for endangering the lives of thousands of patients.

Pradaxa was first approved for sale in the United States in October 2010.

Since then, around 1.1 million prescriptions of Pradaxa has been prescribed to over 371,000 U.S. patients. To prevent fatal bleeding, it is important to be alert for signs of complications. Symptoms of bleeding or hemorrhaging include:

• Lethargy
• Unusual bruising or bleeding/hemorrhaging
• Pink or brown urine
• Coughing up blood
• Vomit that resembles blood
• Frequent nosebleeds
• Headaches
• Joint pain or swelling
• Dizziness
• Weakness and swelling in any or all extremities.

If you or someone you know has experienced serious internal bleeding that might be associated with Pradaxa, it is strongly recommended to consult a defective drug attorney as soon as possible. International drug companies like Behringer Ingelheim are willing to invest millions of dollars protecting their product.

Please call us today for a free and private consultation today, a knowledgeable defective drug attorney can help you pursue justice in the form of a full and fair compensation.